Axsome Therapeutics AXSM
NASDAQ AXSM
$207.06 -1.29 (-0.62%)
As of: Sep 4, 2026 · 3:19 PM EDT

Axsome Therapeutics (AXSM) Gross Margin Growth (3y) (2025 - 2026)

Analysis

Axsome Therapeutics (AXSM) Gross Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -168.00
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -65.00
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 14,836.00
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 589.00
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 53.00
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 569.00
10 Axsome Therapeutics 10.72 Bn 10.40 Bn 204.81 Mn 364.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 364.00
Mar 31, 2026 29.00
Dec 31, 2025 311.00
Sep 30, 2025 445.00
Jun 30, 2025 218.00